Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Jun;96(3):513-22.
doi: 10.1017/s0022172400066316.

Immunoglobulin G, A and M response to influenza vaccination in different age groups: effects of priming and boosting

Immunoglobulin G, A and M response to influenza vaccination in different age groups: effects of priming and boosting

W E Beyer et al. J Hyg (Lond). 1986 Jun.

Abstract

Fifty volunteers, treated with an inactivated trivalent influenza vaccine containing A/Bangkok/1/79 (H3N2), A/Brazil/11/78 (H1N1) and B/Singapore/222/79 virus, were subdivided according to the estimated first exposure to influenza in their lifetime (priming) and the presence of antibodies against the vaccine components in the pre-vaccination sera. The isotypic antibody response (IgG, IgA, IgM) was determined by means of an antibody capture haemadsorption immunosorbent technique. For all three vaccine components, previously seropositive subjects produced antibodies of the IgG- and IgA-class more frequently than previously seronegative persons. Subjects primed to one of the influenza A subtypes showed more IgG and IgA responses in comparison with those unprimed (prime-effect). In contrast, IgM antibodies occurred in only 19 and 11% of primed, but in 59 and 54% of unprimed subjects, for A (H3N2) and A (H1N1), respectively. The incidence of IgM titre rises was not influenced by the prevaccination state. However, the mean magnitude of anti-A (H1N1)-IgM titre rises was greater in those previously seronegative. The concepts of primary and reinfection and of 'original antigenic sin' are discussed, and it is suggested that age and, if possible, serological state prior to antigen-exposure should be taken into account when studying isotypic antibody responses after influenza infection or vaccination.

PubMed Disclaimer

References

    1. Nature. 1968 Apr 6;218(5136):100-1 - PubMed
    1. Virology. 1963 Dec;21:665-6 - PubMed
    1. Am J Epidemiol. 1973 Jan;97(1):44-9 - PubMed
    1. Bull World Health Organ. 1975;52(1):43-50 - PubMed
    1. Dev Biol Stand. 1977 Jun 1-3;39:303-8 - PubMed